Skip to main content

Zimmer Biomet ratios

  • ZBH · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$103.21−1.29%Close 13 Nov 2026

In fiscal 2025 (the year to 31 Dec 2025), Zimmer Biomet had an operating margin of 13.3%, a return on equity of 5.6%, a return on invested capital of 4.7%.

From Zimmer Biomet's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Zimmer Biomet ratios, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Gross margin77.5%75.8%75.8%76.0%74.8%74.8%72.2%73.3%70.0%69.0%72.7%71.4%71.8%70.2%71.3%70.9%71.8%71.5%69.7%
Operating margin28.9%26.4%24.9%21.7%23.0%23.4%23.1%22.2%7.8%10.7%10.2%0.4%14.3%1.4%12.6%10.0%17.3%16.7%13.3%
Net margin19.8%20.6%17.5%14.1%17.1%16.9%16.9%15.4%2.5%4.0%23.2%−4.8%14.2%−2.3%5.9%3.3%13.8%11.8%8.6%
Free cash flow margin22.9%19.1%24.7%26.4%23.9%23.2%18.7%19.6%11.4%18.8%18.3%20.0%17.3%15.7%18.5%15.8%17.5%16.9%17.9%
Return on equity14.2%15.3%12.7%10.5%13.5%13.3%12.8%11.2%1.8%3.1%16.9%−3.3%9.6%−1.1%3.2%1.9%8.4%7.2%5.6%
Return on assets—11.4%9.7%8.1%9.6%9.1%8.9%8.3%2.4%2.3%2.4%0.1%3.7%0.3%3.2%2.3%5.8%5.2%4.2%
Return on capital employed—16.9%15.0%12.7%13.7%13.3%12.8%12.1%2.7%3.3%3.4%0.2%5.3%0.4%4.1%3.6%6.8%6.8%5.6%
Return on invested capital—13.2%11.6%10.0%12.3%12.0%12.3%11.6%2.9%2.6%2.6%0.1%4.1%0.3%3.6%2.5%6.4%5.8%4.7%
Current ratio—2.833.964.283.784.284.074.213.621.961.491.831.371.991.411.881.611.911.98
Debt to equity—0.080.200.200.310.040.020.011.161.160.860.790.680.690.580.490.480.520.61
Net debt / EBITDA—0.180.270.170.36−0.93−1.19−1.138.375.705.177.823.677.733.903.422.522.603.27
Interest coverage——45.4815.2318.5214.3715.2416.441.632.292.44————————
Cash conversion115%92.9%141%187%140%137%111%127%464%473%78.6%−418%122%−694%314%474%126%143%209%
Dividend payout—————12.5%17.0%20.2%107%61.6%10.7%—17.4%—49.8%86.9%19.6%21.7%27.0%
SBC / Revenue1.8%1.7%1.8%1.5%1.4%1.2%1.0%1.1%0.8%0.7%0.7%0.8%1.1%1.2%1.1%1.5%1.3%1.3%1.1%

Quarterly

Zimmer Biomet ratios, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Gross margin72.2%72.9%71.5%70.5%71.0%71.2%71.5%72.1%64.7%72.4%70.8%71.2%
Operating margin18.3%14.1%18.1%15.3%19.2%15.3%14.4%17.6%6.9%17.9%15.0%14.9%
Net margin21.6%9.1%12.5%13.7%11.8%9.5%7.4%11.5%6.2%11.4%9.1%9.3%
Free cash flow margin27.1%9.2%16.3%19.3%22.5%17.7%15.8%18.2%19.7%15.5%18.1%23.5%
Return on equity3.4%1.4%1.9%2.0%1.9%1.5%1.2%1.8%1.1%1.9%1.6%1.5%
Return on assets1.3%1.0%1.3%1.0%1.5%1.1%0.9%1.2%0.5%1.3%1.1%1.1%
Return on capital employed1.9%1.4%2.0%1.5%2.1%1.5%1.5%1.7%0.8%1.9%1.6%1.5%
Return on invested capital1.5%1.1%1.5%1.1%1.7%1.2%1.0%1.4%0.6%1.4%1.2%1.2%
Current ratio1.611.661.291.361.912.441.872.431.981.731.691.46
Debt to equity0.480.460.460.520.520.580.600.640.610.590.590.59
Net debt / EBITDA9.4210.729.1111.099.0810.5912.2710.7416.3310.9611.8412.05
Cash conversion125%100%130%141%190%186%215%158%318%136%198%253%
Dividend payout12.0%28.7%20.3%19.8%20.0%26.3%31.1%20.6%34.1%19.7%23.4%23.9%
SBC / Revenue1.3%1.5%1.4%1.3%1.0%1.0%1.0%1.3%1.1%1.2%1.1%1.2%

The main figures as JSON and plain text. See data and methodology.

ZBH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.